contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


boule-diagnostics-nomination-committee-for-the-annual-general-meeting-2026

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Boule Diagnostics operates in the medical technology industry and focuses on the development and manufacture of diagnostic instruments for hematology. The company's products are aimed at healthcare institutions and laboratories. The business is global with a main presence in Europe, North America and Asia. Boule Diagnostics was founded in 1956 and is headquartered in Spånga, Sweden.

Boule Diagnostics

The 2025 Annual General Meeting of Boule Diagnostics AB (publ), ("Boule"), resolved that a Nomination Committee based on the ownership structure on 30 September 2025 shall be appointed to propose...

<div class="mfn-body"><p>The 2025 Annual General Meeting of Boule Diagnostics AB (publ), ("Boule"), resolved that a Nomination Committee based on the ownership structure on 30 September 2025 shall be appointed to propose the Annual General Meeting 2026:</p><p>1. Proposal for Chairman of the Annual General Meeting,<br>2. Proposal for the Board of Directors,<br>3. Proposal for Chairman of the Board of Directors,<br>4. Proposals for fees and other remuneration for Board assignments to each of the Board members and remuneration for committee work,<br>5. Proposal for auditor,<br>6. Proposal for fees to the Company's auditor,<br>7. Proposal for changes to the principles for the appointment of the Nomination Committee and instructions for the Nomination Committee, to the extent deemed necessary, and<br>8. Other matters that are the responsibility of the Nomination Committee in accordance with the Swedish Corporate Governance Code</p><p>Boule's largest shareholders at the time above were AB Grenspecialisten, Svolder AB and Thomas Eklund, representing 36 percent of the share capital and votes. These shareholders have in turn nominated Tomas Risbecker (Svolder AB), Katarina Berggren (AB Grenspecialisten) and Thomas Eklund. The Nomination Committee has subsequently constituted itself and elected Katarina Berggren as its Chairman and co-opted the Chairman of the Board Torben Jörgensen. Shareholders who wish to get in touch with the Nomination Committee are welcome to contact the Chairman of the Nomination Committee Katarina Berggren via e-mail at <a rel="noopener" href="mailto:katarina.berggren@grenspecialisten.com">katarina@grenspecialisten.com</a>. In order for proposals to be able to be evaluated by the Nomination Committee in the required manner, such proposals should have been submitted no later than 1 February 2026.</p></div><div class="mfn-footer mfn-contacts mfn-5bb0e13f66bc"><p><strong class="mfn-heading-1">Contacts</strong><br>Torben Nielsen, CEO and Group President, <a rel="noopener" href="mailto:torben.nielsen@boule.com">torben.nielsen@boule.com</a>, phone +46 (0)70-558 51 05<br>Holger Lembrér, CFO, <a rel="noopener" href="mailto:holger.lembrer@boule.com">holger.lembrer@boule.com</a>, phone +46 (0)72-230 77 10</p></div><div class="mfn-footer mfn-about mfn-ac6499eab38b"><p><strong class="mfn-heading-1">About Us</strong><br>Boule Diagnostics AB (publ) is a global company consisting of two business segments, Diagnostics and OEM CDS. Diagnostics is specialized in near-patient, decentralized diagnostic solutions for human and veterinary applications, serving hospitals, clinics, laboratories. OEM CDS develops and delivers reliable reagent, blood controls and calibrators tailored for diagnostic companies worldwide. <br>With operations in Sweden, the United States, Mexico, and Russia, and a global distribution network spanning more than 100 countries, Boule combines a resilient business model with strong positions in key growth markets. In 2024, Boule reported net sales of SEK 558 million and has about 200 employees worldwide. Boule has been listed on Nasdaq Stockholm since 2011. <a rel="noopener" href="http://www.boule.com/">http://www.boule.com</a></p></div><div class="mfn-footer mfn-attachment mfn-attachment-general"><p><strong class="mfn-heading-1">Attachments</strong><br><a rel="noopener" href="https://storage.mfn.se/37dbd516-dc9b-4b36-92b6-a27615500610/boule-diagnostics-nomination-committee-for-the-annual-general-meeting-2026.pdf" class="mfn-generated mfn-primary">Boule Diagnostics – Nomination Committee for the Annual General Meeting 2026</a></p></div>